Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Modified SLFN12 increases the amount of UCHL5. 2 / 2

| 2

➶

reach

"SLFN12 or SERPB12 overexpression increases expression of the complementary deubiquitylases USP14 and UCHL5 in vitro, and SERPB12 stimulates USP14 deubiquitylase activity."

30045019

➶

reach

"Either SLFN12 overexpression (XREF_FIG and XREF_FIG) or SERPB12 overexpression (XREF_FIG and XREF_FIG) increased both USP14 (XREF_FIG and XREF_FIG) and UCHL5 (XREF_FIG and XREF_FIG) expression."

30045019

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...